Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Nanologica

0.39 SEK

+0.51 %

Less than 1K followers

NICA

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Nanologica

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue0.66.714.510.82.32.85.221.1
EBITDA-17.0-8.1-43.7-5.6-7.6-8.0-13.2-34.4
EBIT-22.2-11.9-59.3-9.2-10.8-10.0-15.7-46.8
EBIT-%-3,639.3 %-177.1 %-407.6 %-86.0 %-459.8 %-352.3 %-301.7 %-221.5 %
Profit before taxes-23.7-14.0-65.6-10.2-12.3-11.0-16.7-51.3
Net income-23.7-14.0-65.6-10.2-12.3-11.0-16.7-51.3
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.